By contrast, other studies have demonstrated activity of a Fe III 2 -Y• cofactor in NrdF. Sequence alignments of the class Ib and Ia RNRs and a comparison of their crystal structures reveal that they possess the same metal ligands and a tyrosine residue (Y 105 in Ec NrdF) in the appropriate position for oxidation (20, 21) . Metallocofactor self-assembly studies in apoNrdFs from several organisms have been carried out, modeled after those of Atkin and Reichard (22) on the class Ia NrdB. In these experiments, apoNrdF, Fe II , and O 2 were able to form a Fe III 2 -Y• cofactor that was active in nucleotide reduction. Some NrdFs also co-purify with a Fe III 2 -Y• cofactor when overexpressed heterologously in E. coli in rich media. For example, heterologous expression of Salmonella typhimurium (St) NrdF in E. coli resulted in NrdF with 1 Y•/β2 and a SA of 660-850 U/mg (11, 12) , while cofactor selfassembly in vitro from apoNrdF gave 0.4 Y•/β2 and 325 U/mg SA (11) . In general, however, Fe III 2 -Y• NrdFs assembled in vitro or in vivo possess ≤0.5 Y•/β2 and/or activities of <200 U/mg [ Table S1 in (23) ]. Conversely, efforts to self-assemble an active manganese cofactor in St and Ca NrdFs using Mn II and the physiological oxidants O 2 and H 2 O 2 failed to generate significant Y• and activity (11) . As a result of these experiments, the Fe III 2 -Y• has been proposed to be the active cofactor in the class Ib β2s (11, 12) .
Our efforts have recently focused on understanding the biosynthesis and maintenance (regeneration of Y• from inactive, Y•-reduced protein) of the metallocofactors of the E. coli class Ia and Ib RNRs. Analyses of operons of these RNRs (http://theseed.uchicago.edu) and in vitro experiments have revealed that an unusual ferredoxin, YfaE, in the case of class Ia (24, 25) , and an unusual flavodoxin, NrdI, in the case of class Ib (23) , are involved in some way in these pathways in E. coli. Indeed, class Ia and Ib RNRs are distinguished, in part, by the presence of nrdI, often in the same operon as nrdE and nrdF. Recent genetic studies of the class Ib RNR from Streptococcus pyogenes, which does not possess a class Ia enzyme, demonstrated that NrdI is essential for NrdEF activity in vivo (26) .
These studies together have caused us to reinvestigate, in vitro and in vivo, whether a dimanganese-Y• cofactor could be active in nucleotide reduction in the class Ib RNR, with NrdI supplying the oxidant required for metallocofactor assembly. Here we show that NrdI interacts strongly with NrdF and we report the first in vitro generation of a dimanganese-Y• cofactor in Ec NrdF. This reconstitution was successful only when dimanganese(II) NrdF (Mn II 2 -NrdF) was incubated anaerobically with the two-electron reduced, hydroquinone form of NrdI (NrdI hq ), followed by addition of O 2 . A dimanganese-Y• cofactor (0.25 Y•/β2) was generated with a SA of 600 U/mg. EPR analysis supports the proposal that this cofactor is Mn III Our experiments support the hypothesis that NrdI hq provides the oxidant required for assembly of the Mn III 2 -Y• cofactor in NrdF by reacting with O 2 to produce HO 2 − . Such a role is, to our knowledge, unprecedented for a flavodoxin-like protein, although not uncommon in other classes of flavoenzymes (27) . We suggest that this function provides a general explanation for the role of NrdI in vivo, and that the Mn III 2 -Y• cofactor may also be the active form of class Ib RNRs inside the cell. More generally, our results emphasize that in vitro study of metalloproteins must consider their in vivo expression conditions so that the physiologically important metallocofactor is identified.
MATERIALS AND METHODS

General
Chemical reagents were obtained from Sigma-Aldrich in the highest purity available unless otherwise indicated. 2′-Azido-2′-deoxycytidine 5′-diphosphate (N 3 CDP) was synthesized as described (28, 29) . UV-vis spectra were acquired on a Varian Cary 3 UV-vis spectrophotometer. Anaerobic procedures were carried out in a glovebox (MBraun) in a cold room at 4 °C. Protein solutions and buffers for anaerobic work were degassed on a Schlenk line with 5-6 cycles (protein) or 3 cycles (buffer) of evacuation and refilling with Ar prior to introduction into the glovebox. Manganese concentrations were determined using a PerkinElmer AAnalyst 600 atomic absorption spectrometer, and iron was quantitated by the ferrozine method (30 Preparation of Mn II 2 -NrdF ApoNrdF (~500 μM) was expressed in E. coli BL21 Gold (DE3) cells (Stratagene) in the presence of 1,10-phenanthroline as previously described (32) , purified to homogeneity (23) , and stored in Buffer A. For most experiments, Mn II 2 -NrdF was prepared anaerobically by incubation of apoNrdF (330 μM) with 1.32 mM MnCl 2 in Buffer A. For experiments investigating the oxidation state of the dimanganese-Y• cofactor by EPR, Mn II 2 -NrdF (500 μL) was prepared aerobically, the excess Mn II was removed by Sephadex G25 (1 × 6 cm, 5 mL), and the protein was concentrated using an Amicon Ultra 10 kDa MWCO centrifugal filtration device (Millipore) and degassed.
Preparation of NrdI hq
N-terminally His 6 -tagged NrdI (~400 μM) was purified from inclusion bodies as previously described (23) and stored in Buffer C. NrdI (500 μL) was fully reduced by titration with a 5-6 mM solution of sodium dithionite in Buffer C, in a septum-sealed anaerobic cuvette (Starna Cells) fitted with a gas-tight syringe with repeating dispenser (Hamilton) (23) .
Pulldown of Mn II 2 -NrdF with NrdI
In a final volume of 1 mL, 12.5 μM Mn II 2 -NrdF and 25 μM oxidized NrdI (NrdI ox ) were mixed in Buffer B and incubated at 4 °C for 5 min before loading onto a 0.2 mL (0.7 × 1.2 cm) Ni-NTA agarose column (Qiagen). The column was washed with 6 mL Buffer B, 3 mL Buffer B containing 10 mM imidazole, 2 mL Buffer B containing 50 mM imidazole, and 1 mL Buffer B containing 250 mM imidazole. The flowthrough and column washes were collected and analyzed by SDS-PAGE. As a control, an analogous experiment was carried out with 1 mL 12.5 μM Mn II 2 -NrdF in Buffer B, in the absence of NrdI ox .
Anaerobic titration of NrdI in the presence of NrdF
To a septum-sealed anaerobic cuvette fitted with a gas-tight syringe and repeating dispenser, 250 μL of apo-or Mn II 2 -NrdF (36 μM) and NrdI ox (72 μM) were added and mixed with Buffer C. The syringe contained ~1 mM sodium dithionite in Buffer C, which was added in 2 μL aliquots until no further change in the UV-vis spectrum (300 to 800 nm) occurred. Equilibrium was reached after each addition within the time required to mix the sample and to initiate spectrum acquisition.
The spectrum of the anionic semiquinone (sq) form of NrdI was estimated as previously described for the neutral sq (23) . At 293 K, the visible spectrum was acquired of an anaerobic sample of 70 μM NrdI and 35 μM apoNrdF, titrated with dithionite to maximize sq formation. This sample, which now contained ox, sq, and hq forms of NrdI, was then transferred into a sealed aqueous flat cell (Wilmad) in an anaerobic box and its EPR spectrum was acquired at 293 K. Spin quantitation was performed using a Fe III 2 -Y• NrdF sample of known Y• concentration (see below for details). Comparison of the sq concentration, determined by EPR spectroscopy, with the visible spectrum allowed calculation of the extinction coefficient of the anionic sq at 585 nm (only NrdI sq has significant absorption at >550 nm), assuming that all sq was in the anionic form. The resulting value (ε 585nm = 1.5 mM −1 cm −1 ) was used to calculate the concentration of NrdI sq at given points during titrations, thereby allowing determination of the concentrations of NrdI ox and NrdI hq . The spectra of NrdI ox and NrdI hq in the presence of apoNrdF, scaled by concentration, were subtracted from the overall spectrum, yielding the approximate sq spectrum.
In vitro generation of the dimanganese-Y• cofactor
In an anaerobic box, Mn II 2 -NrdF and variable amounts of NrdI hq were mixed with Buffer A (Buffer B) to give a volume of 120 μL. The reactions were initiated by addition of 130 μL O 2 -saturated Buffer A (Buffer B) outside the box. The final reaction mixtures contained 10 μM (50 μM) Mn II 2 -NrdF, 0-20 μM (0-200 μM) NrdI hq , and 1 mM O 2 . After incubation for 1-2 min, 10 μL aliquots were frozen in liquid N 2 and subsequently assayed for activity as described below. The remainder of the solution was transferred to an EPR tube and frozen in liquid N 2 for analysis. Because NrdI is stored in Buffer C, which contains 20% glycerol, the glycerol content of the samples varied between 5 and 12%.
Removal of Mn II from dimanganese-Y• NrdF
Dimanganese-Y• NrdF was prepared in a 250 μL reaction mixture containing 50 μM Mn II 2 -NrdF, 100 μM NrdI hq and 1 mM O 2 , in Buffer B. After 2 min, ethylenediaminetetraacetic acid (EDTA) at a final concentration of 5 mM was added and the reaction mixture incubated at 4 °C for 2 h with gentle rocking. Mn II -EDTA was removed from the protein using a Sephadex G25 column (1 × 6 cm, 5 mL), and the protein was concentrated to the original volume using an Amicon Ultra 10 kDa MWCO centrifugal filtration device and frozen in liquid N 2 for EPR analysis.
Inactivation of dimanganese-Y• NrdF by hydroxyurea (HU) and hydroxylamine
A reaction mixture of 250 μL containing 30 μM Mn II 2 -NrdF, 60 μM NrdI hq , and 1 mM O 2 in Buffer B was prepared as described above. After 2 min, HU or NH 2 OH was added to a final concentration of 30 mM or 1 mM and the samples were incubated at 25 °C for 20 or 5 min, respectively. The HU or NH 2 OH was then removed by Sephadex G25 chromatography (1 × 6 cm, 5 mL) and the protein-containing fraction was frozen and subsequently assayed for activity.
Activity assays
A typical assay reaction contained in a final volume of 135 μL: 0.2 μM reconstituted NrdF (or NrdE), 1.0 μM NrdE (or NrdF), 0.3 mM dATP, 20 mM dithiothreitol (DTT), and 0.5 mM [ 3 H]-CDP (ViTrax, 4800-6500 cpm/nmol), in 50 mM HEPES, 15 mM MgSO 4 , 1 mM EDTA, pH 7.6, at 37 °C (23) . At four timepoints, 30 μL aliquots were removed and heated at 100 °C for 2 min. Subsequent to removal of the phosphates using alkaline phosphatase (Roche), dCDP formation was analyzed by the method of Steeper and Steuart (33) . One unit (U) of activity is equivalent to 1 nmol dCDP produced/min. The SA of N-terminally His 6 -tagged NrdE (23) 
EPR spectroscopy
EPR spectra were acquired on a Brüker EMX X-band spectrometer at 77 K using a quartz finger dewar, at 3.6 to 20 K using an Oxford Instruments liquid helium cryostat, or at 293 K using an aqueous flat cell. All spectra were acquired at 9.3-9.9 GHz, 100 kHz modulation K is a sample-and instrument-dependent constant.
Preparation of Fe III
2 -Y• NrdF ApoNrdF and variable amounts of ferrous ammonium sulfate were mixed anaerobically in Buffer A (227 μL total volume) and incubated for 20 min. O 2 -saturated Buffer A (23 μL) was then added outside the anaerobic box to give a solution containing 50 μM apoNrdF, 0-250 μM Fe II , and 175 μM O 2 . A sample containing 50 μM apoNrdF, 200 μM Fe II , 100 μM NrdI hq , and 175 μM O 2 was also prepared analogously in Buffer B. After 1-2 min, a 10 μL aliquot was removed from each reaction and frozen for subsequent activity assays, and the remainder of the mixture was transferred to an EPR tube and frozen in liquid N 2 for analysis.
Efforts to determine the oxidant generated by reaction of NrdI hq with O 2
Several experiments were carried out to look for evidence for production of O 2
•− by reaction of NrdI hq with O 2 and for cluster assembly in Mn II 2 -NrdF with H 2 O 2 or O 2
•− . The results were negative, and these experiments are described in the Supporting Information (SI).
RESULTS
Attempts to self-assemble active dimanganese-Y• cofactor in the absence of NrdI
Previous attempts to self-assemble an active dimanganese cofactor in vitro starting with St Mn II 2 -NrdF by addition of O 2 or with Ca Mn II 2 -NrdF by addition of O 2 or H 2 O 2 failed to generate any significant Y• or activity (11) . We also attempted self-assembly experiments with E. coli apoNrdF. ApoNrdF was obtained by its overexpression in the presence of 1,10-phenanthroline in the growth medium (23, 32) . The isolated protein contained 0.01 Mn/β2, assayed by atomic absorption spectroscopy, and 0.03 Fe/β2, using the ferrozine assay. Activity assays revealed no detectable dCDP formation.
ApoNrdF was then mixed anaerobically with 4 Mn II /β2 and the EPR spectrum of the resulting material was recorded at 20 K (Figure 1) . The EPR signal, displaying an average effective nuclear hyperfine coupling constant (a Mn ) of 46 G, is consistent with two weakly antiferromagnetically coupled Mn II ions and is similar to the spectra previously reported for the Ca and St Mn II 2 -NrdFs (11) and the Mn II 2 -catalases (38, 39) . Mn II 2 -NrdF was then exposed to either an excess of O 2 (23) . A similar titration carried out in the presence of apoNrdF ( Figure S1A ) gave a surprising result. The spectrum of the one-electron reduced species (Figure 3 , black dotted line, deconvoluted as described in Materials and Methods) revealed the presence of an anionic sq. Comparison of this spectrum to that of the neutral sq demonstrates striking differences, especially in the 350-410 and 550-700 nm regions. The amount of NrdI anionic sq stabilized (31-34%), determined by EPR spectroscopy, was similar to the amount of neutral sq stabilized in the absence of apoNrdF, suggesting that the ox/sq and sq/hq equilibria were not greatly altered. Titrations carried out with Mn II 2 -NrdF in place of apoNrdF gave similar results. Therefore, binding of NrdI to NrdF affects the environment of the flavin in all three of its oxidation states, illustrated most clearly by the altered protonation state of the sq. NrdI's formation of anionic sq in the presence of NrdF is reminiscent of flavoprotein oxidases, which react rapidly with O 2 to form H 2 O 2 , as opposed to flavodoxins, which stabilize neutral sq and react with O 2 to form O 2
•− (27) . This analogy suggests that NrdI's function in the class Ib RNR system may be different than the electron transfer role we have proposed previously (23) .
Finally, when an N-terminally StrepII-tagged NrdF was expressed in the E. coli strain GR536, grown in extreme Fe limitation with Mn added to the growth medium, SDS-PAGE analysis of the purified NrdF also revealed a protein of 15 kDa, consistent with the presence of NrdI (data not shown). The UV-vis spectrum of the purified NrdF suggested the presence of an oxidized flavin (5-10% of NrdF concentration, similar to the SDS-PAGE result), supporting the assignment of the co-purifying protein as NrdI. Thus, results in vitro and in vivo support strong interaction between NrdI and NrdF.
In vitro assembly of an active dimanganese-Y• cofactor in NrdF
Our inability to obtain significant activity in Mn II As shown in Figure 5B , SA/Y• appears to decrease with increasing Y•/β2. We suggest that this result is due to the low SA of our NrdE (α2) It was also observed that Y• reduction by HU and NH 2 OH was accompanied by a slower decrease in the intensity of the trailing absorption feature that we have suggested is associated with an oxidized Mn cluster in dimanganese-Y• NrdF ( Figure 4B , 400-700 nm). In the case of NH 2 OH, a 40% decrease was apparent within 1 min, whereas in the case of HU, no decrease was apparent in the first minute but a 30% decrease was visible within 5 min. After these initial declines, little further decrease was observed over 5 min. These results, suggestive of reduction of oxidized Mn cluster by both HU and NH 2 OH, are consistent with observations that NH 2 OH can reduce the Mn IV Mn III and Mn III 2 forms of Mn catalases (46) . A more detailed analysis of the effects of HU and NH 2 OH on Y• and 2 A reviewer suggested that the residual activity after HU and NH 2 OH treatment may be due to a small amount of a Y•-independent cofactor, such as Mn IV Fe III , which has been identified in the Chlamydia trachomatis class Ic RNR (56). We do not favor this option because we have observed no evidence for an EPR-active Mn III Fe III species upon incubation of Mn III 2 -Y• NrdF with N 3 CDP, NrdE, and dATP (see below). However, we cannot completely rule out the possibility of a small amount of Mn IV Fe III species at present. dimanganese cluster will be carried out once more homogeneous dimanganese-Y• cofactor is obtained. Figure 6A, red line) . The spectrum of the Mn II 2 cluster is broad and a baseline could not be obtained. Therefore, for comparison of the relative amounts of Mn II 2 cluster between the two samples, the peak-to-trough intensity (47) of the most intense Mn II 2 -NrdF hyperfine line was used ( Figure 6A, arrows) . This amplitude was reduced by 45% in dimanganese-Y• NrdF generated with 2 NrdI hq /β2, relative to the Mn II 2 -NrdF and NrdI ox control ( Figure 6A 
The active cofactor is Mn
DISCUSSION
Formation of a Mn III 2 -Y• cofactor
Despite the documented dependence of C. ammoniagenes and other gram-positive bacteria on Mn II for growth, DNA synthesis, and possibly deoxynucleotide formation (8, 17) , general acceptance of the proposal by Follmann, Auling, and coworkers of a Mn-containing class Ib RNR in these organisms (10) has been hindered by the inability to assemble active Mncontaining cofactor in vitro and the low activity of the purified Ca NrdF (11, 13) . In this work, we have demonstrated for the first time that a Mn II 2 -NrdF is competent in vitro to form an active Mn III 2 -Y• cofactor in the presence of NrdI hq and O 2 .
Our assignment of Mn III 2 -Y• as the active form of NrdF is supported by previous experiments with Ca NrdF. The visible spectrum of that protein, reported by Follmann, Auling, and coworkers (10) , is similar to that of μ-oxo, di-μ-carboxylato-Mn III 2 model compounds synthesized by the Wieghardt (52) and Lippard (53) groups. However, our demonstration that NrdI copurifies with NrdF suggests that certain features of the Ca NrdF visible spectrum could have been associated with NrdI. When Ca NrdF was purified by Sjöberg and coworkers (13) , it contained 1 Mn/β2 and was EPR silent. This observation is also consistent with the presence of a Mn III 2 cluster. No Y• was detected by either the Auling or the Sjöberg group, although HU was able to abolish the low levels of activity, suggesting its presence. In neither case was the yield of active enzyme sufficiently high for biophysical characterization. We propose that we have formed in vitro the same NrdF cofactor isolated from C. ammoniagenes, and perhaps more recently from Corynebacterium glutamicum (14) . access to the metal cluster in other class I RNRs (20, 54, 55 
The role of NrdI in Mn
Substoichiometry of Y• formation in NrdF
Our efforts so far to increase Y• content in Mn III 2 -Y• NrdF have been unsuccessful. 3 The complexity of the mechanistic proposal in Scheme 1, however, provides a rationalization for our lack of success. Specifically, in our in vitro reconstitutions, after NrdF-bound NrdI hq reacts with O 2 to form HO 2 − and Mn III 2 -NrdF, it must be reduced by another NrdI hq in solution. This is expected to be an inefficient process due to disproportionation of the ox and hq forms to form sq. Alternatively, orchestration of the sequential binding of two NrdI hq s to NrdF with the appropriate timing would also be challenging. These gymnastics could be avoided in vivo with a physiological reductant. NrdI could then act catalytically.
We also investigated whether NrdI hq could reduce the Y• of Mn III 2 -Y• cofactor, thereby contributing to the substoichiometric Y• content (see SI). We found that, although Y• content was reduced from 0.3 to 0.2 Y•/β2 over 30 min, this reduction is likely too slow to contribute significantly in the cluster assembly reactions, which are complete within seconds. We therefore favor the absence of the putative NrdI reductase as the explanation for substoichiometric Mn III 2 -Y• cofactor assembly in our in vitro reconstitutions. We are currently using a bioinformatic approach to identify this protein.
Implications for the maintenance pathway
The requirement for 2 eq HO 2 − in cluster assembly also requires that the NrdI hq bound to In other organisms that depend on the class Ib RNR for DNA replication in aerobic growth, it is possible that both diiron and dimanganese cofactors are used in vivo, depending on the growth conditions. Several observations suggest, however, that in these organisms as well, the Mn III 2 -Y• cofactor may be active. First, studies in C. ammoniagenes (8, 17) Therefore, our current hypothesis is that NrdF contains the Mn III 2 -Y• cofactor in E. coli and related enterobacteria, whereas the identity of the cofactor in other organisms containing class Ib RNRs may depend on the specific organism and/or growth conditions. We are working to establish the metal requirements of NrdF proteins under a variety of growth conditions in several prokaryotes by integrating N-terminally tagged nrdFs into genomes for expression at endogenous levels.
The in vitro activity of both Mn III 2 -Y• and Fe III 2 -Y• cofactors in NrdF underscores the importance of the cellular metallocofactor assembly machinery (e.g. chaperone proteins, metal transporters, and deliverers of reducing equivalents), which may not be available when metalloproteins are expressed heterologously in rich media. In vivo studies must accompany in vitro studies, to ensure the metalloenzymes being examined in molecular detail are physiologically relevant.
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FIGURE 3.
Spectra of the ox (solid lines), sq (dotted lines), and hq (dashed lines) forms of NrdI in the presence (black) and absence (red) of apoNrdF, in Buffer C. The spectra of the neutral and anionic sq forms were estimated as described in Materials and Methods. Proposed mechanism for formation of Mn III 2 -Y• NrdF by NrdI hq and O 2 .
